Invasive Streptococcus pneumoniae from Portugal: Implications for vaccination and antimicrobial therapy

Clinical Microbiology and Infection

Volumn 10, Issue 7, 2004, Pages 652-656

  Serrano, I ^a   Ramirez, M ^a   Melo Cristino, J ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Antimicrobial therapy; Pneumococci; Streptococcus pneumoniae; Therapy; Vaccination

Indexed keywords

CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; EUROPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 4043097641     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00869.x     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49:1-29.
2. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100-121.
3. Sahm DF, Karlowsky JA, Kelly LJ et al. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob Agents Chemother 2001; 45: 1037-1042.
4. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993; 31: 2097-2100.
5. Melo-Cristino J, Fernandes ML, Serrano N, the Portuguese Surveillance Group for the Study of Respiratory Pathogens. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Microb Drug Resist 2001; 7: 33-38.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, Twelfth Informational Supplement. Standard M1OO-S12. Wayne, PA: NCCLS, 2002.
7. Dagan R, Givon-Lavi N, Zamir O et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002; 185: 927-936.
8. Bernaola Iturbe E, Aristegui Fernandez JdJ, Herranz Aguirre M, Garcia Calvo C, Fernandez Perez C. Estudio de la incidencia de enfermedad neumocócica invasora entre 0-5 años en el Páis Vasco y Navarra. An Esp Pediatr 2002; 57: 301-309.
9. Flamaing J, Verhaegen J, Peetermans WE. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother 2002; 50: 43-50.
10. Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 1995; 9: 358-365.
11. Sleeman K, Knox K, George R et at. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 2001; 183: 239-246.
12. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
13. Jackson LA, Neuzil KM, Yu O et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-1755.
14. Campbell GD, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1998; 26: 1188-1195.
15. De Lencastre H, Kristinsson KG, Brito-Avo A et al. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. Microb Drug Resist 1999; 5: 19-29.
16. Baquero F, Garcia-Rodriguez JA, Garcia de Lomas J, Aguilar L. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother 1999; 43: 357-359.